360 related articles for article (PubMed ID: 28098253)
1. The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication.
Sacramento CQ; de Melo GR; de Freitas CS; Rocha N; Hoelz LV; Miranda M; Fintelman-Rodrigues N; Marttorelli A; Ferreira AC; Barbosa-Lima G; Abrantes JL; Vieira YR; Bastos MM; de Mello Volotão E; Nunes EP; Tschoeke DA; Leomil L; Loiola EC; Trindade P; Rehen SK; Bozza FA; Bozza PT; Boechat N; Thompson FL; de Filippis AM; Brüning K; Souza TM
Sci Rep; 2017 Jan; 7():40920. PubMed ID: 28098253
[TBL] [Abstract][Full Text] [Related]
2. The FDA-approved drug sofosbuvir inhibits Zika virus infection.
Bullard-Feibelman KM; Govero J; Zhu Z; Salazar V; Veselinovic M; Diamond MS; Geiss BJ
Antiviral Res; 2017 Jan; 137():134-140. PubMed ID: 27902933
[TBL] [Abstract][Full Text] [Related]
3. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
4. Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae.
Ferreira AC; Zaverucha-do-Valle C; Reis PA; Barbosa-Lima G; Vieira YR; Mattos M; Silva PP; Sacramento C; de Castro Faria Neto HC; Campanati L; Tanuri A; Brüning K; Bozza FA; Bozza PT; Souza TML
Sci Rep; 2017 Aug; 7(1):9409. PubMed ID: 28842610
[TBL] [Abstract][Full Text] [Related]
5. Cell-line dependent antiviral activity of sofosbuvir against Zika virus.
Mumtaz N; Jimmerson LC; Bushman LR; Kiser JJ; Aron G; Reusken CBEM; Koopmans MPG; van Kampen JJA
Antiviral Res; 2017 Oct; 146():161-163. PubMed ID: 28912011
[TBL] [Abstract][Full Text] [Related]
6. Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.
Xu HT; Hassounah SA; Colby-Germinario SP; Oliveira M; Fogarty C; Quan Y; Han Y; Golubkov O; Ibanescu I; Brenner B; Stranix BR; Wainberg MA
J Antimicrob Chemother; 2017 Mar; 72(3):727-734. PubMed ID: 28069884
[TBL] [Abstract][Full Text] [Related]
7. Sofosbuvir Selects for Drug-Resistant Amino Acid Variants in the Zika Virus RNA-Dependent RNA-Polymerase Complex In Vitro.
Boccuto A; Dragoni F; Picarazzi F; Lai A; Della Ventura C; Veo C; Giammarino F; Saladini F; Zehender G; Zazzi M; Mori M; Vicenti I
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800884
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus.
Snyder B; Goebel S; Koide F; Ptak R; Kalkeri R
J Med Virol; 2018 Jan; 90(1):8-12. PubMed ID: 28851097
[TBL] [Abstract][Full Text] [Related]
9. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
Vicenti I; Boccuto A; Giannini A; Dragoni F; Saladini F; Zazzi M
Virus Res; 2018 Jan; 244():64-70. PubMed ID: 29113824
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.
Quintana VM; Selisko B; Brunetti JE; Eydoux C; Guillemot JC; Canard B; Damonte EB; Julander JG; Castilla V
Antiviral Res; 2020 Apr; 176():104749. PubMed ID: 32081740
[TBL] [Abstract][Full Text] [Related]
12. The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6MMPr) effectively blocks Zika virus replication.
de Carvalho OV; Félix DM; de Mendonça LR; de Araújo CMCS; de Oliveira Franca RF; Cordeiro MT; Silva Júnior A; Pena LJ
Int J Antimicrob Agents; 2017 Dec; 50(6):718-725. PubMed ID: 28803932
[TBL] [Abstract][Full Text] [Related]
13. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
Kamiyama N; Soma R; Hidano S; Watanabe K; Umekita H; Fukuda C; Noguchi K; Gendo Y; Ozaki T; Sonoda A; Sachi N; Runtuwene LR; Miura Y; Matsubara E; Tajima S; Takasaki T; Eshita Y; Kobayashi T
Antiviral Res; 2017 Oct; 146():1-11. PubMed ID: 28818572
[TBL] [Abstract][Full Text] [Related]
14. The antiviral effect of metformin on zika and dengue virus infection.
Farfan-Morales CN; Cordero-Rivera CD; Osuna-Ramos JF; Monroy-Muñoz IE; De Jesús-González LA; Muñoz-Medina JE; Hurtado-Monzón AM; Reyes-Ruiz JM; Del Ángel RM
Sci Rep; 2021 Apr; 11(1):8743. PubMed ID: 33888740
[TBL] [Abstract][Full Text] [Related]
15. Beyond Members of the
Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
[TBL] [Abstract][Full Text] [Related]
16. Zika Virus Replicons for Drug Discovery.
Xie X; Zou J; Shan C; Yang Y; Kum DB; Dallmeier K; Neyts J; Shi PY
EBioMedicine; 2016 Oct; 12():156-160. PubMed ID: 27658737
[TBL] [Abstract][Full Text] [Related]
17. Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess the efficacy of potential antivirals.
Tricot T; Helsen N; Kaptein SJF; Neyts J; Verfaillie CM
PLoS One; 2018; 13(12):e0209097. PubMed ID: 30566505
[TBL] [Abstract][Full Text] [Related]
18. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
de Freitas CS; Higa LM; Sacramento CQ; Ferreira AC; Reis PA; Delvecchio R; Monteiro FL; Barbosa-Lima G; James Westgarth H; Vieira YR; Mattos M; Rocha N; Hoelz LVB; Leme RPP; Bastos MM; Rodrigues GOL; Lopes CEM; Queiroz-Junior CM; Lima CX; Costa VV; Teixeira MM; Bozza FA; Bozza PT; Boechat N; Tanuri A; Souza TML
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007072. PubMed ID: 30699122
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus.
Pitts JD; Li PC; de Wispelaere M; Yang PL
Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080
[TBL] [Abstract][Full Text] [Related]
20. Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication.
Vicenti I; Dragoni F; Giannini A; Giammarino F; Spinicci M; Saladini F; Boccuto A; Zazzi M
SLAS Discov; 2020 Jun; 25(5):506-514. PubMed ID: 32186426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
